KAVCAPA Trademark

Trademark Overview

On Monday, August 29, 2022, a trademark application was filed for KAVCAPA with the United States Patent and Trademark Office. The USPTO has given the KAVCAPA trademark a serial number of 97569422. The federal status of this trademark filing is REGISTERED as of Tuesday, September 2, 2025. This trademark is owned by AstraZeneca AB. The KAVCAPA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
kavcapa

General Information

Serial Number97569422
Word MarkKAVCAPA
Filing DateMonday, August 29, 2022
Status700 - REGISTERED
Status DateTuesday, September 2, 2025
Registration Number7924356
Registration DateTuesday, September 2, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Thursday, September 1, 2022NEW APPLICATION ENTERED
Friday, September 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 3, 2023ASSIGNED TO EXAMINER
Friday, March 10, 2023NON-FINAL ACTION WRITTEN
Friday, March 10, 2023NON-FINAL ACTION E-MAILED
Friday, March 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 23, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, May 23, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, September 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 24, 2024ASSIGNED TO LIE
Wednesday, January 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 2, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, February 8, 2024ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 8, 2024NOTICE OF ALLOWANCE CANCELLED
Monday, December 9, 2024TEAS REQUEST FOR REINSTATEMENT
Monday, December 9, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2024TEAS DELETE 1(B) BASIS RECEIVED
Monday, December 9, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, January 21, 2025ASSIGNED TO PETITION STAFF
Tuesday, September 2, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, September 2, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, August 11, 20251(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, January 22, 2025REINSTATEMENT GRANTED - REQUEST TO DELETE 1(B) FILED
Monday, August 11, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

kavcapa pharmaceutical substances preparations disorders diseases treatment infection hematological inflammation autoimmune